Globus Medical (NYSE: GMED) has announced a definitive agreement to acquire all shares of Nevro Corp. (NYSE: NVRO) in an ...

AUDUBON, Pa. - Globus Medical , Inc. (NYSE: NYSE:GMED), a prominent musculoskeletal solutions company with a market capitalization of $11.81 billion and an "GREAT" financial health rating according to ...

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical ...

Flex, a new, comprehensive digital wellness program, puts the power of muscle and joint health in its user’s hands. As a ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain relief following surgery or injury, the ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

More than 30 percent of adults in the U.S. are living with chronic or severe pain. If you’re part of that statistic, you know how devastating living with severe or daily pain can be. Treating ...

Developing a robust approach to mitigating the current opioid crisis in the USA will require translating novel evidence-based, neuroscience-informed treatments into clinical care and public policy.

Research indicates CBD may play a promising complementary role in pain management ... about using CBD to curb pain and the symptoms of chronic pain conditions like arthritis, among others.